It was an honour to be invited to speak at the internal launch of Allergan’s latest injectable product, Juvéderm® Volite, yesterday.
Volite is Allergan’s first injectable designed to specifically address skin quality and is suitable for treating the face, neck, décolletage and hands.
Clinical data has so far shown strong improvements in skin hydration and elasticity and reductions in fine lines. Results can last up to 9 months with a single treatment.
Volite is composed of hyaluronic acid (“HA”). HA is found in abundance in our skin, cartilage, joints and the fluid in our eyes and is the most water-loving molecule known to man. Around 1/3rd of our total HA is made and broken down daily, and as we age our bodies’ natural ability to regenerate HA slowly decreases.
As part of the initial evaluation phase, my patients have already shown strong improvements in skin quality and I’m looking forward to offering this treatment to all our patients at S-Thetics.
S-Thetics is an award winning state-of-the-art medical aesthetic clinic located in the heart of Beaconsfield Old Town in Buckinghamshire, specialising in advanced non-surgical treatments for the face and body.
Founded by surgeon and cosmetic doctor, Miss Sherina Balaratnam, S-Thetics offer a broad range of treatments within our menu – from advanced skincare products and facial treatments, to cosmetic injectables and non-surgical skin rejuvenation using medical grade technology.
We are proud to have a medical approach at the heart of our practice, meaning that all treatments we offer have scientific backing and are delivered with the highest standard of clinical expertise and care.
Miss Balaratnam is a “Local Country Ambassador” (LCA) for Allergan, the manufacturers of BOTOX® and the Juvederm® Ultra range of fillers.
As one of only a handful of expert UK practitioners selected as an LCA, she regularly trains and mentor other health care professionals in non-surgical cosmetic rejuvenation treatments and injection techniques and I am actively involved in training programmes both within the UK as well as internationally.